GF FUND MANAGEMENT CO. LTD.
Position in ADPT — Adaptive Biotechnologies Corp
CIK 2057060
GUANGZHOU, F4
Position in ADPT
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$0
+$0 QoQ
Shares Held
815
-5.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ADPT Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GF FUND MANAGEMENT CO. LTD. holds $24,168,575 across 17 Diagnostics & Research names. ADPT ranks #17 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | IDXX |
Idexx Laboratories Inc /De
|
18,120 | $9,539,092 | |
| 2 | TMO |
Thermo Fisher Scientific Inc.
|
10,234 | $5,130,918 | |
| 3 | DHR |
Danaher Corp /De/
|
17,492 | $3,331,876 | |
| 4 | A |
Agilent Technologies, Inc.
|
7,785 | $1,034,081 | |
| 5 | WAT |
Waters Corp /De/
|
2,681 | $1,005,482 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
4,482 | $866,012 | |
| 7 | MTD |
Mettler Toledo International Inc/
|
570 | $728,180 | |
| 8 | LH |
Labcorp Holdings Inc.
|
2,310 | $646,800 |
All Filings in ADPT
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 3,260 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | — | 3,430 | Shares | Sole | 2026-04-15 | |
| 2025-12-31 | — | 2,998 | Shares | Sole | 2026-01-27 | |
| 2025-09-30 | — | 3,276 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | — | 3,779 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | — | 3,779 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | — | 3,099 | Shares | Sole | 2025-02-19 | |
| No filing history on record for this holder in this stock. | ||||||